Principles of Neural Repair and Their Application to Stroke Recovery Trials.


Journal

Seminars in neurology
ISSN: 1098-9021
Titre abrégé: Semin Neurol
Pays: United States
ID NLM: 8111343

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 5 3 2021
medline: 15 12 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

Neural repair is the underlying therapeutic strategy for many treatments currently under investigation to improve recovery after stroke. Repair-based therapies are distinct from acute stroke strategies: instead of salvaging threatened brain tissue, the goal is to improve behavioral outcomes on the basis of experience-dependent brain plasticity. Furthermore, timing, concomitant behavioral experiences, modality specific outcome measures, and careful patient selection are fundamental concepts for stroke recovery trials that can be deduced from principles of neural repair. Here we discuss core principles of neural repair and their implications for stroke recovery trials, highlighting related issues from key studies in humans. Research suggests a future in which neural repair therapies are personalized based on measures of brain structure and function, genetics, and lifestyle factors.

Identifiants

pubmed: 33663003
doi: 10.1055/s-0041-1725140
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-166

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

David J Lin (DJ)

Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
VA RR&D Center for Neurorestoration and Neurotechnology, Rehabilitation R&D Service, Department of VA Medical Center, Providence, Rhode Island.

Steven C Cramer (SC)

Department of Neurology, University of California, Los Angeles, California.
California Rehabilitation Institute, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH